139 related articles for article (PubMed ID: 989639)
1. Various prothrombin complex concentrates and their effect on coagulation and fibrinolysis in vivo.
Hedner U; Nilsson IM; Bergentz SE
Thromb Haemost; 1976 Apr; 35(2):386-95. PubMed ID: 989639
[TBL] [Abstract][Full Text] [Related]
2. Comparison of high purity factor IX concentrates and a prothrombin complex concentrate in a canine model of thrombogenicity.
MacGregor IR; Ferguson JM; McLaughlin LF; Burnouf T; Prowse CV
Thromb Haemost; 1991 Nov; 66(5):609-13. PubMed ID: 1803625
[TBL] [Abstract][Full Text] [Related]
3. [The action of peanut extract on the blood coagulation system].
Novak EN
Farmakol Toksikol; 1966; 29(5):568-71. PubMed ID: 5995068
[No Abstract] [Full Text] [Related]
4. Biochemical and in vivo properties of high purity factor IX concentrates.
Berntorp E; Björkman S; Carlsson M; Lethagen S; Nilsson IM
Thromb Haemost; 1993 Nov; 70(5):768-73. PubMed ID: 8128433
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs.
Négrier C; Menart C; Attali O; Petit PY; Lienhart A; Dechavanne M; Ingerslev J
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S135-41. PubMed ID: 9819045
[TBL] [Abstract][Full Text] [Related]
6. Prothrombin overload causes thromboembolic complications in prothrombin complex concentrates: in vitro and in vivo evidence.
Grundman C; Plesker R; Kusch M; Hanschmann KM; Eich S; Seitz R; König H
Thromb Haemost; 2005 Dec; 94(6):1338-9. PubMed ID: 16411418
[No Abstract] [Full Text] [Related]
7. A novel rat model of thrombogenicity: its use in evaluation of prothrombin complex concentrates and high purity factor IX concentrates.
McLaughlin LF; Drummond O; MacGregor IR
Thromb Haemost; 1992 Nov; 68(5):511-5. PubMed ID: 1455396
[TBL] [Abstract][Full Text] [Related]
8. [The effect of aminazine on blood coagulation].
Novak EN
Farmakol Toksikol; 1972; 35(6):717-20. PubMed ID: 4651808
[No Abstract] [Full Text] [Related]
9. Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation.
Pechet L; Groth CG; Daloze PM
J Lab Clin Med; 1969 Jan; 73(1):91-102. PubMed ID: 4883102
[No Abstract] [Full Text] [Related]
10. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
[TBL] [Abstract][Full Text] [Related]
11. [Effect of calcium chloride on blood coagulation].
Novak EN; Iadrova VM
Farmakol Toksikol; 1967; 30(2):192-5. PubMed ID: 5599523
[No Abstract] [Full Text] [Related]
12. Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates.
Köhler M; Hellstern P; Lechler E; Uberfuhr P; Müller-Berghaus G
Thromb Haemost; 1998 Sep; 80(3):399-402. PubMed ID: 9759617
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement].
Sokołowska B; Piecuch W; Walter-Croneck A; Dmoszyńska A; Furmanik F
Przegl Lek; 2002; 59(7):502-8. PubMed ID: 12516238
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
15. Potentially thrombogenic materials in factor IX concentrates.
Kingdon HS; Lundblad RL; Veltkamp JJ; Aronson DL
Thromb Diath Haemorrh; 1975 Jun; 33(3):617-31. PubMed ID: 1154317
[TBL] [Abstract][Full Text] [Related]
16. Prothrombin complex concentrates for clinical use.
Chandra S; Brummelhuis HG
Vox Sang; 1981; 41(5-6):257-73. PubMed ID: 6798760
[TBL] [Abstract][Full Text] [Related]
17. Increased fibrinopeptide A after prothrombin complex concentrates.
Viganó S; Cattaneo M; Gervasoni W; Mannucci PM
Thromb Haemost; 1980 Oct; 44(2):72-5. PubMed ID: 6779400
[TBL] [Abstract][Full Text] [Related]
18. Studies on the thrombogenicity of Scottish factor IX concentrates in dogs.
Cash JD; Dalton RG; Middleton S; Smith JK
Thromb Diath Haemorrh; 1975 Jun; 33(3):632-9. PubMed ID: 1154318
[No Abstract] [Full Text] [Related]
19. Factor IX thrombogenicity: in vivo effects on coagulation activation and a case report of disseminated intravascular coagulation.
Small M; Lowe GD; Douglas JT; Forbes CD; Prentice CR
Thromb Haemost; 1982 Aug; 48(1):76-7. PubMed ID: 7135346
[TBL] [Abstract][Full Text] [Related]
20. Serial changes in the coagulation system following clotting factor concentrate infusion.
Preston FE; Winfield DA; Malia RG; Blackburn EK
Thromb Diath Haemorrh; 1975 Nov; 34(2):475-82. PubMed ID: 1198408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
